RxDoctor Payments Data

Anthony Defranzo, MD

Plastic Surgery · Winston Salem, NCNPI 1073598017

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,510 of the $3,953 with a category attached, or 63.5%. BD accounts for 63.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $1,467 and has fallen 75.4% since, to $360 in 2025.

$3,953in general payments, 2019–2025

Across 19 payments — averaging $208.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$3K
  • Sientra, Inc.$343
  • Mentor Worldwide LLC$247
  • Solventum Corporation$147
  • Davol Inc.$135
  • Polarityte, Inc.$115
  • plus $456 from 5 others

What the payments were for

  • Consulting fees$2,51064%
  • Food & beverage$1,44336%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD7$2,510
Sientra, Inc.2$343
Mentor Worldwide LLC2$247
Solventum Corporation1$147
Davol Inc.1$135
Polarityte, Inc.1$115
Musculoskeletal Transplant Foundation Inc.1$108
TEI Biosciences Inc1$106
Axogen1$106
Integra Lifesciences Corporation1$97
TEI Medical Inc.1$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,953 in reported general payments places this provider in the 60th percentile of 128 plastic surgery providers in North Carolina.

See all plastic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$23,901
Medicare patients
146
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imiquimod26$495

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →